Oncimmune signs agreement with Cedars-Sinai to profile immune response to COVID-19
LONDON: Oncimmune Holdings plc has signed a commercial agreement with Cedars-Sinai, California, USA, to provide antibody profiling in COVID-19 samples as biomarkers for this disease,...